- Herman Waldmann
Herman Waldmann, FRS, is a British
immunologist (born27 February 1945 ). He worked in the Department of Pathology,University of Cambridge , from 1973, becoming head of the Immunology Division in 1989. He was made a Fellow of theRoyal Society in 1990. In 1994, he took up the position of head of the Sir William Dunn School of Pathology at theUniversity of Oxford .Waldmann is best known for his work on therapeutic monoclonal antibodies, particularly Campath-1, now licensed as
alemtuzumab for the treatment ofchronic lymphocytic leukemia .External links
* [http://hcr3.isiknowledge.com/author.cgi?&link1=Search&link2=Search%20Results&AuthLastName=Waldmann&AuthFirstName=Hermann&AuthMiddleName=&AuthMailnstName=&CountryID=-1&DisciplineID=0&id=1998 Biography at ISI Highly Cited Researchers]
* [http://users.path.ox.ac.uk/~scobbold/tig/welcome.html Sir William Dunn School of Pathology Therapeutic Immunology Group] -- photo, links to CV & publications list
* [http://users.path.ox.ac.uk/~scobbold/tig/CAMPATH/CAMPHIST.HTM From laboratory to clinic: the story of CAMPATH-1 (Geoff Hale and Herman Waldmann)]
Wikimedia Foundation. 2010.